COVA-302

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCOVA-302
Drug Alias NameBispecific IL-1/IL-17A Inhibitor Protein (Covagen)bispecific proteins (Covagen)COVA-302
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterleukin-17 inhibitorsInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptorInterleukin-17
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCovagen Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCovagen Ag
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A